Evidence OSMedical evidence & research
Back to customer servicesHealth-consumer products and wellbeing providers

You changed the wellbeing device. Does the old evidence still apply?

A relaxation, massage, sleep or digital-wellness product has new materials, output parameters or algorithms. Distributors ask for evidence, while the team still cites old versions or similar devices.

How does this scope address your concerns?

Similar appearance can be mistaken for equivalent effects. Before-and-after feelings may replace evidence matching the actual version and use.

When this scope fits
  • Relaxation, sleep, everyday or digital-wellness teams with defined model, version, purpose, outputs and use records.
  • R&D and distribution teams assessing evidence consequences and next validation investment for one version change.
When the scope needs adjusting
  • Medical-device classification, treatment claims or clinical use require qualified regulatory and specialist review of the route first.
  • Testing, safety certification, registration and study execution are outside evidence-review scope.
REAL SOURCES · ILLUSTRATIVE REQUEST · DOWNLOADABLE SAMPLE

Massage pad v2: one version change, three evidence tasks

Download sample packZIP

v1 → v2 change-to-evidence matrix

01Pressure distribution

Assumed changed; old output materials do not automatically cover it

02Preset modes

Assumed changed; verify use and software version

03Comfort experience

Measure this version with defined time points and comparison

04Pain treatment

Not inferred from short-term experience

FDA 2026 guidance informs discussion of general wellness versus disease-related use; it is not a risk classification or authorisation for this pad.

CheckFinding / sample contentUse
Reusable materialv1 identity and study methods inform review; effects need separate assessmentRecord change impact and reuse rationale item by item
Evidence sequenceCheck technical output before choosing experience comparisonsList bench, usability and experience-study tasks separately
SOURCES USED IN THIS EXAMPLE
  1. FDA 2026: General Wellness — policy for low risk devices
  2. MDCG 2020-5: Clinical evaluation — equivalence
Prepared 5 Oct 2026 · Selected references, not an exhaustive systematic search

Scope & acceptance

Work covered by the quote

  • Agree one product version, old/comparison products, use, population, claims and record volume.
  • Deliver version differences, claim-to-evidence mapping, applicability and gaps, plus a testing/research framework.
  • Testing, clinical research, certification and submissions are not included automatically; establish specialist routes for medical or high-risk uses.
  • Quoted after scoping. Change complexity, technical-record completeness, claims, study volume and engineering/health review affect workload.
  • Bench tests, laboratories, prototypes, human measurements and certification require separate quotations and approval.
  • Agree review-phase fees and a budget ceiling. New settings, users or models require approved additional scope.

Acceptance criteria

  • Model, hardware/software version, outputs, use dose and users are identified.
  • Engineering, safety, experience and health outcomes are separated; transfer from other versions/products has reasons and limits.
  • Each key gap links to a concrete measurement/testing requirement, relevant specialist role and implementation conditions.

Checking the evidence

  • Use actual technical/version records, authorised original studies, test reports and use schedules.
  • Evidence matching is research evaluation. Classification, test-provider qualifications, certification and market-specific law require separate competent review.
Workflow and inputs

From inputs to delivery

Explore the workflow and deliverable structure. This preview does not run searches, read real records or produce medical findings.

01 / WORKFLOW PREVIEW

Define the version being sold

Confirm model, software, parameters, users, dose and claim; obtain change records.

What becomes visible

Identity and change tables prevent citing a study of a different version.

Methods, sources and professional responsibilities
THE BASIS FOR THIS SCOPE

Why this approach? Inspect the basis.

Check the match between product, population, use conditions and outcomes before defining a supported claim.

OFFICIAL GUIDANCE

FTC · Health Products

Federal Trade Commission · US

Does the research match the product claim?

Scientific support for health-product claims should match the product and claim, rather than merely a similar ingredient.

Scope & access conditions

This is US guidance. Other markets require separate assessment; it is not an approval or compliance conclusion.

Open official source
PUBLIC DATABASE

ClinicalTrials.gov

NLM / NIH

Check studies and reported results

Review study objectives, eligibility, locations, status and reported results, then identify questions for the clinical team.

Scope & access conditions

Sponsors or investigators submit the records. A listing is not government approval of safety or effectiveness, or a determination that you should participate.

Read the official description
Open official source
METHOD REFERENCE

GRADE · Cochrane Handbook

Cochrane · Chapter 14

Show effect size and confidence separately

Present important outcomes, relative and absolute effects, available data and certainty, with reasons for downgrading.

Scope & access conditions

GRADE evaluates a body of evidence for a particular outcome. Database inclusion or one study does not automatically establish high certainty.

Open official source

These references support problem definition and evidence appraisal. Your conclusions still require project-specific sources and professional review.

The value of this commissionEOS separates engineering, experience and health-outcome evidence and specifies measurable gaps for the current version.

Wellbeing experience and consumer-product evidenceCompare alternatives and value

Where is the gap between product parameters, user experience and a health benefit?

What to assessExponentEvidence OS · Commissioned scope
Service focusExponent combines UX testing, study design, data collection and claim evaluation.EOS separates engineering, experience and health-outcome evidence and specifies measurable gaps for the current version.
When to chooseChoose teams explicitly offering laboratories, user testing and execution when those are required.A pilot may lock one version, one use process and up to three claims; each gap maps to a test or evaluation task.
What the fee pays for
Quoted by scope; evidence review and protocol first, with venue, device testing and execution budgets separate.
Value beyond this task
Reuse version identities, measures and consumer Q&A when sites or parameters change.
How to assess value
Track avoidable study spend, repeat preparation and claim rework; measure experience/health benefits in studies.

Check service/product boundaries, actual parameters and adverse experiences; no healing certification or predetermined ranking.

References for research definitions and review methods

These sources inform product, population, use-condition and review definitions. Findings about a particular product require its original research; claims and submission requirements are checked for the target market.

Reuse and updates after delivery
  • Keep a product-version-to-evidence register for engineering updates, distributor questions and supply-chain handover.
  • Focus validation on changes that could affect a claim and avoid repeatedly citing mismatched studies. Effects, certification and sales are not guaranteed.

Agree reuse rights, retention and export periods, and future update fees when scoping.

Questions before commissioning

Can similar devices share one study?

Compare purpose, materials, output, contact, dose and users first. Related-device studies may inform context and design but do not automatically validate your version.

Does safety testing establish a health benefit?

Safety, engineering performance, experience and health effects address different questions. A test supports what it measured, not automatic relaxation or treatment effects.

Must we review an algorithm-only update?

Changes to output, recommendations, interaction, dose or users can affect applicability. Record the differences before deciding whether new validation is needed.

Define the delivery for your actual question.

Add your goal, available inputs and timing. Agree scope, review responsibilities and a quote before commissioning.

Request scope & quote
Explore other situations
Health-consumer products and wellbeing providers

You have ingredient papers. What do they actually show about your finished product?

Receive an ingredient-to-product evidence table, claim boundaries, conflicting findings and gaps, with options to obtain missing records, narrow the claim or study the finished product.

Quoted by scopeSee the deliverable
Health-consumer products and wellbeing providers

Is the new formula worth another study? Define the one thing it must show first.

Receive a version-specific gap list, priority research question, primary outcome and measurement schedule, comparator options and staged budget inputs.

Quoted by scopeSee the deliverable
Health-consumer products and wellbeing providers

Evidence for meditation is not automatically evidence for your app. What is yours missing?

Receive a version-and-content evidence map, measurable support goals, population boundaries, gaps and study-design elements that also track adverse experiences.

Quoted by scopeSee the deliverable
Health-consumer products and wellbeing providers

An employer wants your stress-support service. Can you show what it changes?

Receive a version-specific evaluation design covering users, primary outcome, comparator, timing, service dose and delivery records, with findings separated from purchasing assumptions.

Quoted by scopeSee the deliverable
Health-consumer products and wellbeing providers

People love the experience. What does your wellbeing service actually provide?

Receive a version-specific question, measurable experience and support outcomes, relevant and inapplicable research, risk/adverse-feedback records and a staged evaluation plan.

Quoted by scopeSee the deliverable
Health-consumer products and wellbeing providers

Your product is preparing for agent-assisted procurement, but its health claims lack a verifiable evidence dossier.

Within an agreed scope, receive a machine-readable JSON dossier, a readable product explanation, a claim-to-source table and an evidence-gap list, with product versions, evidence dates, human-review and disclosure status.

Quote after scope confirmationSee the deliverable
Health-consumer products and wellbeing providers

Several health products claim to work. Before procurement, you need to know whose evidence fits your customers.

Receive a supplier-evidence comparison, source and missing-data records, comparison JSON, disagreement notes and a study-gap list. Agreed humans review the materials; authorised staff separately decide purchasing conditions, ranking criteria and orders.

Quote after scope confirmationSee the deliverable